• Revenue Cycle Management
  • COVID-19
  • Diabetes Awareness Month
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Patients want more discussion of alternatives to stenting


Not enough of you are presenting your coronary stent patients with ways to avoid the procedure, according to a new study.

Not enough of you are presenting your coronary stent patients with alternatives to the procedure, according to a new study.

The study in the Journal of General Internal Medicine surveyed fee-for-service Medicare beneficiaries who had elective coronary artery stenting in the last half of 2008. Only 10% said they were presented with an alternative to surgery as a serious option. Most (77%) reported talking with their doctors "a lot" or "some" about the reasons for the surgery, but only 19% reported talking about the drawbacks, and only 16% said they were asked about their treatment preference.

By contrast, 64% of patients who underwent surgery for prostate cancer reported having at least one alternative to surgery presented to them as a serious option.

Related Videos
Robert E. Oshel, PhD
Gary Price, MD, MBA
Victor J. Dzau, MD, gives expert advice
Ron Holder, MHA, gives expert advice
remote patient monitoring
no shows
effective meetings
© 2023 MJH Life Sciences

All rights reserved.